Volterra paper published in leading health policy journal

Respiratory journalA report led by Volterra associate Professor Nick Bosanquet was recently published and featured in the Primary Care Respiratory Journal. The research paper reviews and compares methods currently employed in the research and treatment of chronic obstructive pulmonary disease (COPD) in a number of target regions and countries. The paper reviews the evidence on programme development and the effectiveness gap between health outcomes in the UK, France, Germany, and Finland. The results show the need for more specific programmes in primary care in order to close this effectiveness gap. Such a programme should aim to target and prevent the downward spiral for high–risk patients. Read the report here.

Share this post

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email

ELLIE EVANS

Partner

e: eevans@volterra.co.uk
t: +44 020 8878 6333

Ellie is a partner at Volterra, specialising in the economic impact of developments and proposals, and manages many of the company’s projects on economic impact, regeneration, transport and development.

With thirteen years experience at Volterra delivering high quality projects to clients across the public and private sector, Ellie has expertise in developing methods of estimating economic impact where complex issues exist with regards to deadweight, displacement and additionality.

Ellie has significant experience in estimating the economic impact across all types of property development including residential, leisure, office and mixed use schemes.

Project management of recent high profile schemes include the luxury hotel London Peninsula, Battersea Power Station and the Nova scheme at London Victoria. Ellie has also led studies across the country estimating the economic and regeneration impact of proposed transport investments, including studies on HS2 and Crossrail.

Ellie holds a degree in Mathematics and Economics from the University of Cambridge.